Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Analyst Ratings

• Total Analysts: 4
• Consensus Rating: Buy
• Price Target: $12.25
• Upside: +187.56%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $16	Buy	Reiterates	$16	+275.59%	Jun 28, 2024
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $11	Buy	Reiterates	$11	+158.22%	May 22, 2024
Robert Driscoll Wedbush	Wedbush	Buy Initiates $11	Buy	Initiates	$11	+158.22%	Feb 15, 2024
Eric Joseph JP Morgan	JP Morgan	Buy Maintains $31 → $11	Buy	Maintains	$31 → $11	+158.22%	Oct 19, 2023
Richard Law Credit Suisse	Credit Suisse	Hold Reiterates $11	Hold	Reiterates	$11	+158.22%	Aug 11, 2023
Richard Law Credit Suisse	Credit Suisse	Hold Reiterates $11	Hold	Reiterates	$11	+158.22%	May 12, 2023
Richard Law Credit Suisse	Credit Suisse	Hold Maintains $12 → $11	Hold	Maintains	$12 → $11	+158.22%	Mar 17, 2023
Derek Archila Wells Fargo	Wells Fargo	Hold → Buy Upgrades $19	Hold → Buy	Upgrades	$19	+346.01%	Jan 3, 2023
Eliana Merle UBS	UBS	Strong Buy Initiates $22	Strong Buy	Initiates	$22	+416.43%	Oct 13, 2022
Kelly Shi Jefferies	Jefferies	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+369.48%	Aug 15, 2022
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $40 → $21	Buy	Maintains	$40 → $21	+392.96%	May 12, 2022
Richard Law Credit Suisse	Credit Suisse	Hold Initiates $19	Hold	Initiates	$19	+346.01%	Apr 28, 2022
Derek Archila Wells Fargo	Wells Fargo	Hold Initiates $19	Hold	Initiates	$19	+346.01%	Feb 10, 2022
Andrew Berens SVB Leerink	SVB Leerink	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Oct 14, 2021
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jul 19, 2021
Eric Joseph JP Morgan	JP Morgan	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jul 19, 2021